1
|
Omari S, Ng'ong'a F, Kimotho J. In vitro assessment and comparison of quality of alcohol-based hand rubs, pre- and peri-COVID-19 pandemic outbreak in Kenya. F1000Res 2024; 12:1546. [PMID: 38778804 PMCID: PMC11109557 DOI: 10.12688/f1000research.140226.3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Accepted: 05/07/2024] [Indexed: 05/25/2024] Open
Abstract
Background In the wake of the coronavirus disease 2019 (COVID-19) pandemic, the World Health Organization recommended the use of alcohol-based hand rubs (ABHRs) to curb transmission, leading to increased production and use. This has posed a danger of production and use of poor-quality ABHRs. Methods This study assessed and compared the quality of ABHRs in the Kenyan market that were produced before and after the outbreak of the COVID-19 pandemic in March 2020. Quality testing was carried out against European EN 1500:2013 and Kenyan EAS 789:2013 Standards and 20 samples analyzed for alcohol content by GC-FID. Results The study found that 27.8% of the peri-COVID-19 pandemic sanitizers had less than 90% bactericidal reduction activity as compared to 12.5% manufactured pre-COVID-19 pandemic. Only 25% peri-COVID-19 pandemic ABHRs met the EAS 789:2013 acceptable limit of over 60% alcohol content. Product adulteration with methanol was found in 20 % of the samples with only 5% complying with FDA approval limit of <0.063% v/v methanol. Study found no correlation between the total alcohol content and the efficacy of ABHRs. Conclusions The study found that more substandard products were produced during the pandemic. This raises a concern about possible emergence of alcohol resistant strains of microorganisms. The study therefore recommends an adequate quality monitoring system to curb against substandard products.
Collapse
Affiliation(s)
- Samuel Omari
- Department of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
- Innovation and Technology Transfer Division, Kenya Medical Research Institute, Nairobi, Kenya
| | - Florence Ng'ong'a
- Innovation and Technology Transfer Division, Kenya Medical Research Institute, Nairobi, Kenya
| | - James Kimotho
- Department of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
| |
Collapse
|
2
|
Daiba AR, Kagira JM, Ngotho M, Kimotho J, Maina N. In vitro anticoccidial activity of nanoencapsulated bromelain against Eimeria spp. oocysts isolated from goats in Kenya. Vet World 2022; 15:397-402. [PMID: 35400962 PMCID: PMC8980396 DOI: 10.14202/vetworld.2022.397-402] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/02/2021] [Accepted: 01/17/2022] [Indexed: 11/16/2022] Open
Abstract
Background and Aim: The emergence of drug-resistant strains of Eimeria spp. calls for the development of novel anticoccidial drugs. Plant extracts provide a possible natural source for such drugs. This study aimed to investigate the in vitro anticoccidial activity of encapsulated bromelain (EB) in chitosan nanocarriers on Eimeria spp. oocysts isolated from goats kept by farmers in Kenya. Materials and Methods: Bromelain was extracted from the peel of ripe pineapples using standard methods. Eimeria spp. oocysts were isolated from the feces of goats using a flotation method. The inhibition of sporulation was assayed after exposing the oocysts to solutions of EB, non-EB (NEB), and diclazuril (positive control) at concentrations between 4 mg/mL and 0.125 mg/mL for 48 h. The oocysts were examined under a microscope (40x) to determine the effects of the drugs on the sporulation process. The percentage of sporulation inhibition was calculated after 48 h and the inhibition concentration 50% (IC50) was determined by probit analysis. Results: Bromelain manifested anticoccidial activity through the inhibition of the sporulation of coccidia oocysts. EB achieved inhibition with a lower dose compared with NEB. The IC50 values of diclazuril, EB, and NEB were 0.078 mg/mL, 0.225 mg/mL, and 0.575 mg/mL, respectively. There were significant differences (p<0.01) between the IC50 of EB and NEB compared with the standard treatment drug. Conclusion: This preliminary study showed that EB has anticoccidial activity supporting further evaluation at an in vivo level to develop a novel drug for the management of coccidiosis in goats.
Collapse
Affiliation(s)
- Ahmota Romain Daiba
- Department of Molecular Biology and Biotechnology, Pan-African University of Institute of Basic Science, Technology and Innovation, Nairobi, Kenya
| | - John Maina Kagira
- Department of Animal Sciences, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
| | - Maina Ngotho
- Department of Clinical Studies, University of Nairobi, Nairobi, Kenya
| | - James Kimotho
- Innovation and Technology Transfer Division, Kenya Medical Research Institute, Nairobi, Kenya
| | - Naomi Maina
- Department of Molecular Biology and Biotechnology, Pan-African University of Institute of Basic Science, Technology and Innovation, Nairobi, Kenya; Department of Biochemistry, Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
| |
Collapse
|
3
|
Ndegwa L, Hatfield KM, Sinkowitz-Cochran R, D’Iorio E, Gupta N, Kimotho J, Woodard T, Chaves SS, Ellingson K. Evaluation of a program to improve hand hygiene in Kenyan hospitals through production and promotion of alcohol-based Handrub - 2012-2014. Antimicrob Resist Infect Control 2019; 8:2. [PMID: 30622703 PMCID: PMC6318974 DOI: 10.1186/s13756-018-0450-x] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/21/2018] [Accepted: 12/11/2018] [Indexed: 11/17/2022] Open
Abstract
Although critical to prevent healthcare-associated infections, hand hygiene (HH) compliance is poor in resource-limited settings. In 2012, three Kenyan hospitals began onsite production of alcohol-based handrub (ABHR) and HH promotion. Our aim is to determine the impact of local production of ABHR on HH compliance and perceptions of ABHR. We observed 25,738 HH compliance opportunities and conducted 15 baseline and post-intervention focus group discussions. Hand Hygiene compliance increased from 28% (baseline) to 38% (post-intervention, p = 0.0003). Healthcare workers liked the increased accessibility of ABHR, but disliked its smell, feel, and sporadic availability. Onsite production and promotion of ABHR resulted in modest HH improvement. Enhancing the quality of ABHR and addressing logistical barriers could improve program impact.
Collapse
Affiliation(s)
- Linus Ndegwa
- Influenza Program, US Centers for Disease Control and Prevention-Kenya, Nairobi, Kenya
| | - Kelly M. Hatfield
- Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA USA
| | - Ronda Sinkowitz-Cochran
- Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA USA
| | - Emily D’Iorio
- Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA USA
| | - Neil Gupta
- Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA USA
| | - James Kimotho
- Production Unit, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
| | - Tiffanee Woodard
- Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA USA
| | - Sandra S. Chaves
- Influenza Program, US Centers for Disease Control and Prevention-Kenya, Nairobi, Kenya
- Influenza Division, National Center for Immunization and Respiratory Disease, US Centers for Disease Control and Prevention, Atlanta, GA USA
| | - Katherine Ellingson
- Division of Healthcare Quality Promotion, US Centers for Disease Control and Prevention, Atlanta, GA USA
- Department of Epidemiology and Biostatistics, The University of Arizona College of Public Health, Tucson, Arizona USA
| |
Collapse
|
4
|
Ochwoto M, Muita L, Talaam K, Wanjala C, Ogeto F, Wachira F, Osman S, Kimotho J, Ndegwa L. Anti-bacterial efficacy of alcoholic hand rubs in the Kenyan market, 2015. Antimicrob Resist Infect Control 2017; 6:17. [PMID: 28138386 PMCID: PMC5264297 DOI: 10.1186/s13756-017-0174-3] [Citation(s) in RCA: 12] [Impact Index Per Article: 1.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/06/2016] [Accepted: 01/11/2017] [Indexed: 11/10/2022] Open
Abstract
Background Hand hygiene is known to be effective in preventing hospital and community-acquired infections. The increasing number of hand sanitizer brands in Kenyan hospitals and consumer outlets is of concern. Thus the main aim of this study was to evaluate the anti-bacterial efficacy and organoleptic properties of these hand sanitizers in Kenya. Methods This was an experimental, laboratory-based study of 14 different brands of hand sanitizers (coded HS1-14) available in various retail outlets and hospitals in Kenya. Efficacy was evaluated using standard non-pathogenic Escherichia coli (ATCC 25922), Staphylococcus aureus (ATCC 25923) and Pseudomonas aeruginosa (ATCC 27853) as per the European Standard (EN). The logarithmic reduction factors (RF) were assessed at baseline and after treatment, and log reduction then calculated. Ten and 25 healthy volunteers participated in the efficacy and organoleptic studies respectively. Results Four (28.6%) hand sanitizers (HS12, HS9, HS13 and HS14) showed a 5.9 reduction factor on all the three bacteria strains. Seven (50%) hand sanitizers had efficacies of <3 against all the three bacteria strains used. Efficacy on E. Coli was higher compared to the other pathogens. Three hand sanitizers were efficacious on one of the pathogens and not the other. In terms of organoleptic properties, gel-based formulations were rated far higher than the liquid based formulations brands. Conclusion Fifty percent (50%) of the selected hand sanitizers in the Kenyan market have efficacy that falls below the World Health Organization (WHO) and DIN EN 1500:2013. Of the 14 hand sanitizers found in the Kenyan market, only four showed efficacies that were comparable to the WHO-formulation. There is a need to evaluate how many of these products with <3 efficacy that have been incorporated into the health system for hand hygiene and the country’s policy on regulations on their usage.
Collapse
Affiliation(s)
- Missiani Ochwoto
- Production Department, Kenya Medical Research Institute, P. O. Box 54840-00200, Nairobi, Kenya
| | - Lucy Muita
- Production Department, Kenya Medical Research Institute, P. O. Box 54840-00200, Nairobi, Kenya
| | - Keith Talaam
- Production Department, Kenya Medical Research Institute, P. O. Box 54840-00200, Nairobi, Kenya
| | - Cecilia Wanjala
- Production Department, Kenya Medical Research Institute, P. O. Box 54840-00200, Nairobi, Kenya
| | - Frank Ogeto
- Production Department, Kenya Medical Research Institute, P. O. Box 54840-00200, Nairobi, Kenya
| | - Faith Wachira
- Production Department, Kenya Medical Research Institute, P. O. Box 54840-00200, Nairobi, Kenya
| | - Saida Osman
- Production Department, Kenya Medical Research Institute, P. O. Box 54840-00200, Nairobi, Kenya
| | - James Kimotho
- Production Department, Kenya Medical Research Institute, P. O. Box 54840-00200, Nairobi, Kenya
| | - Linus Ndegwa
- Centers for Disease Control and Prevention, Nairobi, Kenya
| |
Collapse
|
5
|
Ngaira JAM, Kimotho J, Mirigi I, Osman S, Ng'ang'a Z, Lwembe R, Ochwoto M. Prevalence, awareness and risk factors associated with Hepatitis B infection among pregnant women attending the antenatal clinic at Mbagathi District Hospital in Nairobi, Kenya. Pan Afr Med J 2016; 24:315. [PMID: 28154670 PMCID: PMC5267875 DOI: 10.11604/pamj.2016.24.315.9255] [Citation(s) in RCA: 28] [Impact Index Per Article: 3.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/03/2016] [Accepted: 07/21/2016] [Indexed: 01/21/2023] Open
Abstract
INTRODUCTION Hepatitis B Viral Infection (HBV) remains one of the leading cause of morbidity and mortality globally accounting for 38-53% of chronic liver diseases and about 686,000 deaths annually. The prevalence of HBV is 9-20% in Sub-Saharan Africa, and in Kenya it is 5-30% among the general population and 9.4% among pregnant women. This study was aimed at identifying the prevalence, awareness and risk factors associated with HBV infections among pregnant women attending Antenatal clinic (ANC) at Mbagathi District hospital, Nairobi. METHODS This was a cross-sectional study involving 287 pregnant women enrolled for three months (September to December 2014) from Nairobi and neighbouring counties. A structured questionnaire that captured social, demographic and explanatory variables was administered to the study participants. Blood samples were also drawn from the participants and tested for HBV using Enzyme-Linked Immunosorbent Assay (ELISA) system. RESULTS The study established that the prevalence of HBV infections among pregnant women attending antenatal clinic at Mbagathi District Hospital was 3.8% with highest infection rate among the 20-24 years age group. Seventy six (60.8 %) of the participants reported sexual encounters in less than a month before the interview of which 5 (7.6%) reported encounters involving other partners apart from their spouses. HBV awareness among the study participants was 12.2%. Before the interview, those with at least tertiary education (Mean =1.33, SD = 1.131), were more informed about HBV infection as compared to those with primary and secondary education (Mean = 0.63, SD = 0.722; (Mean =0.31, SD= 0.664). In regards to assessment of the risk factors; type of family (χ² =19.753 df2 p<0.01), parity (χ² =7.128 df2 p<0.01), History of abortions (χ²=9.094 df1 p<0.01), early age (11-15 years) at first sexual encounter (χ² =8.185 df1 p<0.01) were significantly associated with HBV positivity. CONCLUSION The prevalence of HBV infection among pregnant women attending Antenatal clinic (ANC) at Mbagathi District hospital, Nairobi was lower (3.8%) than the prevalence among pregnant women nationally (9.4%). These women also showed a low level of HBV awareness (12.2%.).
Collapse
Affiliation(s)
| | | | | | | | - Zipporah Ng'ang'a
- Jomo Kenyatta University of Agriculture and Technology, Institute of Tropical Medicine and Infectious Diseases, Kenya; Southern Eastern Kenya University, Kenya
| | | | | |
Collapse
|
6
|
Ochwoto M, Kimotho J, Oyugi J, Andonov A, Songok E, Osiowy C. Hepatitis B virus genotypes and unique recombinants circulating among outpatients in selected hospitals in Kenya. Int J Infect Dis 2016. [DOI: 10.1016/j.ijid.2016.02.957] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022] Open
|
7
|
Wasonga C, Inoue S, Rumberia C, Michuki G, Kimotho J, Ongus JR, Sang R, Musila L. Genetic divergence of Chikungunya virus plaque variants from the Comoros Island (2005). Virus Genes 2015; 51:323-8. [PMID: 26347221 DOI: 10.1007/s11262-015-1243-4] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/17/2015] [Accepted: 08/23/2015] [Indexed: 11/29/2022]
Abstract
Chikungunya virus (CHIKV) from a human sample collected during the 2005 Chikungunya outbreak in the Comoros Island, showed distinct and reproducible large (L2) and small (S7) plaques which were characterized in this study. The parent strain and plaque variants were analysed by in vitro growth kinetics in different cell lines and their genetic similarity assessed by whole genome sequencing, comparative sequence alignment and phylogenetic analysis. In vitro growth kinetic assays showed similar growth patterns of both plaque variants in Vero cells but higher viral titres of S7 compared to L2 in C6/36 cells. Amino acids (AA) alignments of the CHIKV plaque variants and S27 African prototype strain, showed 30 AA changes in the non-structural proteins (nsP) and 22 AA changes in the structural proteins. Between L2 and S7, only two AAs differences were observed. A missense substitution (C642Y) of L2 in the nsP2, involving a conservative AA substitution and a nonsense substitution (R524X) of S7 in the nsP3, which has been shown to enhance O'nyong-nyong virus infectivity and dissemination in Anopheles mosquitoes. The phenotypic difference observed in plaque size could be attributed to one of these AA substitutions. Phylogenetic analysis showed that the parent strain and its variants clustered closely together with each other and with Indian Ocean CHIKV strains indicating circulation of isolates with close evolutionary relatedness in the same outbreak. These observations pave way for important functional studies to understand the significance of the identified genetic changes in virulence and viral transmission in mosquito and mammalian hosts.
Collapse
Affiliation(s)
- Caroline Wasonga
- Department of Biochemistry, University of Nairobi, P. O. Box 30197-00100, Nairobi, Kenya. .,Arbovirus/Viral Haemorrhagic Fever Laboratory, Kenya Medical Research Institute (KEMRI), P. O. Box 54840-00200, Nairobi, Kenya.
| | - Shingo Inoue
- Department of Virology, Institute of Tropical Medicine, Nagasaki University, 1-12-4, Sakamoto, Nagasaki, 852-8523, Japan
| | - Cecilia Rumberia
- Department of Biological Sciences, International Livestock Research Institute, P. O. Box 3079- 00100, Nairobi, Kenya
| | - George Michuki
- Department of Biological Sciences, International Livestock Research Institute, P. O. Box 3079- 00100, Nairobi, Kenya
| | - James Kimotho
- Production Department, Kenya Medical Research Institute (KEMRI), P. O. Box 54840-00200, Nairobi, Kenya
| | - Juliette R Ongus
- Medical Laboratory Sciences Department, Jomo Kenyatta University of Agriculture and Technology, P. O. Box 62000-00200, Nairobi, Kenya.,Molecular Biology and Bioinformatics Unit, International Centre of Insect Physiology and Ecology, P. O. Box 30772 - 00100, Nairobi, Kenya
| | - Rosemary Sang
- Arbovirus/Viral Haemorrhagic Fever Laboratory, Kenya Medical Research Institute (KEMRI), P. O. Box 54840-00200, Nairobi, Kenya
| | - Lillian Musila
- Department of Emerging Infectious Diseases, United States Army Medical Research Unit - Kenya, P. O. Box 606 - 00621, Village Market, Nairobi, Kenya
| |
Collapse
|
8
|
Wasonga C, Inoue S, Kimotho J, Morita K, Ongus J, Sang R, Musila L. Development and Evaluation of an in-House IgM-Capture ELISA for the Detection of Chikungunya and Its Application to a Dengue Outbreak Situation in Kenya in 2013. Jpn J Infect Dis 2015; 68:410-4. [PMID: 25866119 DOI: 10.7883/yoken.jjid.2014.482] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
Abstract
Chikungunya (CHIK) is a mosquito-borne viral disease. In the 2004 CHIK outbreak in Kenya, diagnosis was delayed because of the lack of accurate diagnostics. Therefore, this study aimed to develop and evaluate an in-house IgM-capture enzyme linked immunosorbent assay (ELISA) (in-house ELISA) for the detection of chikungunya virus (CHIKV) infections. Anti-CHIKV antibodies were raised in rabbits, purified and conjugated to horseradish peroxidase. These anti-CHIKV antibodies and cell-culture derived antigen were used to develop the ELISA. To validate the in-house ELISA, 148 patient sera from the 2005 Comoros CHIK outbreak were tested with centers for disease control and prevention (CDC) IgM-capture ELISA (CDC ELISA) and focus reduction neutralization test (FRNT) as reference assays. The in-house ELISA had a sensitivity of 97.6% and specificity of 81.3% compared to the CDC ELISA and a sensitivity of 91.1% and specificity of 96.7% compared to FRNT. Furthermore, 254 clinically suspected dengue patient samples from Eastern Kenya, collected in 2013, were tested for CHIKV IgM using the in-house ELISA. Out of the 254 samples, 26 (10.2%) were IgM positive, and of these 26 samples, 17 were further analyzed by FRNT and 14 (82.4%) were positive. The in-house ELISA was able to diagnose CHIKV infection among suspected dengue cases in the 2013 outbreak.
Collapse
|
9
|
Fujii Y, Kaneko S, Nzou SM, Mwau M, Njenga SM, Tanigawa C, Kimotho J, Mwangi AW, Kiche I, Matsumoto S, Niki M, Osada-Oka M, Ichinose Y, Inoue M, Itoh M, Tachibana H, Ishii K, Tsuboi T, Yoshida LM, Mondal D, Haque R, Hamano S, Changoma M, Hoshi T, Kamo KI, Karama M, Miura M, Hirayama K. Serological surveillance development for tropical infectious diseases using simultaneous microsphere-based multiplex assays and finite mixture models. PLoS Negl Trop Dis 2014; 8:e3040. [PMID: 25078404 PMCID: PMC4117437 DOI: 10.1371/journal.pntd.0003040] [Citation(s) in RCA: 33] [Impact Index Per Article: 3.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/25/2013] [Accepted: 06/10/2014] [Indexed: 11/29/2022] Open
Abstract
Background A strategy to combat infectious diseases, including neglected tropical diseases (NTDs), will depend on the development of reliable epidemiological surveillance methods. To establish a simple and practical seroprevalence detection system, we developed a microsphere-based multiplex immunoassay system and evaluated utility using samples obtained in Kenya. Methods We developed a microsphere-based immuno-assay system to simultaneously measure the individual levels of plasma antibody (IgG) against 8 antigens derived from 6 pathogens: Entamoeba histolytica (C-IgL), Leishmania donovani (KRP42), Toxoplasma gondii (SAG1), Wuchereria bancrofti (SXP1), HIV (gag, gp120 and gp41), and Vibrio cholerae (cholera toxin). The assay system was validated using appropriate control samples. The assay system was applied for 3411 blood samples collected from the general population randomly selected from two health and demographic surveillance system (HDSS) cohorts in the coastal and western regions of Kenya. The immunoassay values distribution for each antigen was mathematically defined by a finite mixture model, and cut-off values were optimized. Findings Sensitivities and specificities for each antigen ranged between 71 and 100%. Seroprevalences for each pathogen from the Kwale and Mbita HDSS sites (respectively) were as follows: HIV, 3.0% and 20.1%; L. donovani, 12.6% and 17.3%; E. histolytica, 12.8% and 16.6%; and T. gondii, 30.9% and 28.2%. Seroprevalences of W. bancrofti and V. cholerae showed relatively high figures, especially among children. The results might be affected by immunological cross reactions between W. bancrofti-SXP1 and other parasitic infections; and cholera toxin and the enterotoxigenic E. coli (ETEC), respectively. Interpretation A microsphere-based multi-serological assay system can provide an opportunity to comprehensively grasp epidemiological features for NTDs. By adding pathogens and antigens of interest, optimized made-to-order high-quality programs can be established to utilize limited resources to effectively control NTDs in Africa. Monitoring the distribution of neglected tropical diseases (NTDs) is a key to controlling their spread in Africa. Currently, such surveillance is conducted independently for each NTD. To tackle this problem, we developed a microsphere-based system to permit simultaneous measurement of IgG antibody levels for antigens from six infectious diseases: Entamoeba histolytica, Leishmania donovani, Toxoplasma gondii, Wuchereria bancrofti, HIV, and Vibrio cholerae. Using this system, we conducted a serological survey using two health and demographic surveillance system (HDSS) areas in coastal and western Kenya. We randomly selected 4,600 individuals according to sex and age group, of whom 3411 agreed to participate in the study. Mathematical analyses of the distributions of the participants' reactivity to each antigen and the reactivity of the sero-positive and -negative controls indicated that this system could be used to monitor infections, especially, those associated with HIV, filariasis, toxoplasmosis, leishmaniasis, and amebiasis. For the practical development and eventual implementation of actual programs in Africa, pathogens and antigens of interest can be added to optimize made-to-order monitoring programs.
Collapse
Affiliation(s)
- Yoshito Fujii
- Department of Eco-Epidemiology, Institute of Tropical Medicine, Nagasaki University (NUITM), Nagasaki, Japan
| | - Satoshi Kaneko
- Department of Eco-Epidemiology, Institute of Tropical Medicine, Nagasaki University (NUITM), Nagasaki, Japan
- Graduate School of International Health Development, Nagasaki University, Nagasaki, Japan
- Nagasaki University Institute of Tropical Medicine (NUITM)- Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
- * E-mail:
| | - Samson Muuo Nzou
- Nagasaki University Institute of Tropical Medicine (NUITM)- Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
- Centre for Infectious and Parasitic Diseases Control Research, Kenya Medical Research Institute (KEMRI), Busia, Kenya
| | - Matilu Mwau
- Centre for Infectious and Parasitic Diseases Control Research, Kenya Medical Research Institute (KEMRI), Busia, Kenya
| | - Sammy M. Njenga
- Eastern & Southern Africa Centre of International Parasite Control (ESACIPAC), Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
| | - Chihiro Tanigawa
- Department of Eco-Epidemiology, Institute of Tropical Medicine, Nagasaki University (NUITM), Nagasaki, Japan
| | - James Kimotho
- Production Department, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
| | - Anne Wanjiru Mwangi
- Production Department, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
| | - Ibrahim Kiche
- Nagasaki University Institute of Tropical Medicine (NUITM)- Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
- Thomas Odhiambo Campus, Mbita, International Center of Insect Physiology and Ecology (ICIPE), Mbita, Kenya
| | - Sohkichi Matsumoto
- Department of Bacteriology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - Mamiko Niki
- Department of Bacteriology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - Mayuko Osada-Oka
- Department of Bacteriology, Osaka City University Graduate School of Medicine, Osaka, Japan
- Food Hygiene and Environmental Health Division of Applied Life Science, Graduate School of Life and Environmental Sciences, Kyoto Prefectural University, Kyoto, Japan
| | - Yoshio Ichinose
- Nagasaki University Institute of Tropical Medicine (NUITM)- Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
- Kenya Research Station, Nagasaki University, Nagasaki, Japan
| | - Manabu Inoue
- Department of Bacteriology, Osaka City University Graduate School of Medicine, Osaka, Japan
| | - Makoto Itoh
- Department of Infection and Immunology, Aichi Medical University School of Medicine, Nagakute, Aichi, Japan
| | - Hiroshi Tachibana
- Department of Infectious Diseases, Tokai University School of Medicine, Kanagawa, Japan
| | - Kazunari Ishii
- Department of Microbiology and Immunology, Faculty of Medicine, Fukuoka University, Fukuoka, Japan
| | - Takafumi Tsuboi
- Division of Malaria Research, Proteo-Science Center, Ehime University, Ehime, Japan
| | - Lay Myint Yoshida
- Department of Paediatric Infectious Diseases, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
| | - Dinesh Mondal
- International Center for Diarrheal Disease Research (ICDDR, B), Dhaka, Bangladesh
| | - Rashidul Haque
- International Center for Diarrheal Disease Research (ICDDR, B), Dhaka, Bangladesh
| | - Shinjiro Hamano
- Nagasaki University Institute of Tropical Medicine (NUITM)- Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
- Department of Parasitology, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
| | - Mwatasa Changoma
- Nagasaki University Institute of Tropical Medicine (NUITM)- Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
| | - Tomonori Hoshi
- Department of Eco-Epidemiology, Institute of Tropical Medicine, Nagasaki University (NUITM), Nagasaki, Japan
| | - Ken-ichi Kamo
- Department of Liberal Arts and Sciences, Sapporo Medical University, Sapporo, Japan
| | - Mohamed Karama
- Graduate School of International Health Development, Nagasaki University, Nagasaki, Japan
- Centre of Public Health Research, Kenya Medical Research Institute (KEMRI), Nairobi, Kenya
| | - Masashi Miura
- Department of Eco-Epidemiology, Institute of Tropical Medicine, Nagasaki University (NUITM), Nagasaki, Japan
| | - Kenji Hirayama
- Department of Immunogenetics, Institute of Tropical Medicine, Nagasaki University, Nagasaki, Japan
| |
Collapse
|
10
|
Ochwoto M, Chauhan R, Gopalakrishnan D, Chen CY, Ng'ang'a Z, Okoth F, Kioko H, Kimotho J, Kaiguri P, Kramvis A. Genotyping and molecular characterization of hepatitis B virus in liver disease patients in Kenya. Infect Genet Evol 2013; 20:103-10. [PMID: 23978387 DOI: 10.1016/j.meegid.2013.08.013] [Citation(s) in RCA: 26] [Impact Index Per Article: 2.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Received: 04/12/2013] [Revised: 08/15/2013] [Accepted: 08/18/2013] [Indexed: 12/17/2022]
Abstract
Hepatitis B virus (HBV) genotypes are important in both the clinical manifestation of disease and treatment response. Although Kenya belongs to the African Region (AFR-E) characterized by high mortality and hyperendemicity of HBV, there is a paucity of HBV genotyping data. The aim of this study was to molecularly characterize the basic core promoter/precore (BCP/PC) and complete surface (S) regions of HBV isolated from 61 HBsAg-positive liver disease patients attending Kenyatta National Hospital in Nairobi. HBsAg, HBeAg and viral loads were determined. HBV DNA was amplified and sequenced from 58/61 patients. In addition to the complete genome of two isolates, the BCP/PC and the complete S regions of 43 and 38 isolates, respectively were sequenced. Following phylogenetic analysis of the S region, 38 isolates clustered with subgenotype A1, whereas two isolates clustered with genotype D, one with subgenotype D1 and another as an outlier of the clade containing subgenotype D6 and the D/E recombinant. When the complete genome of the latter isolate was sequenced it clustered with D6. The majority of isolates belonged to serological subtype adw2 and only four to ayw2. Three distinct groups of subgenotype A1, distinguished by different amino acid motifs, circulate in Kenya: two in the African cluster and a monophyletic clade in the "Asian" cluster. HBeAg-negativity was a result of G1896A in genotype D isolates, whereas in subgenotype A1, the HBeAg-negativity was a result of mutations in the Kozak region (1809-1812) or precore start codon (1814-1816). Mutations at positions 1762 and 1764 occurred more frequently in HCC patients (p<0.05). In conclusion, subgenotypes A1, D1 and D6 circulate in liver disease patients in Kenya, with A1 predominating.
Collapse
Affiliation(s)
- Missiani Ochwoto
- Hepatitis Virus Diversity Research Programme (HVDRP), Department of Internal Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa; Kenya Medical Research Institute (KEMRI), Kenya; Jomo Kenyatta University of Agriculture and Technology (JKUAT), Kenya.
| | | | | | | | | | | | | | | | | | | |
Collapse
|